2017
DOI: 10.1177/1352458517720528
|View full text |Cite
|
Sign up to set email alerts
|

Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis

Abstract: This second result in an independent group of patients supports the idea that neuromodulation interventions that properly select a personalized target might be a suitable non-pharmacological treatment for MS fatigue.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
78
0
7

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(89 citation statements)
references
References 37 publications
(61 reference statements)
4
78
0
7
Order By: Relevance
“…Other studies in PwMS also showed no significant improvements on fatigue questionnaires from unilateral prefrontal or parietal tDCS stimulation applied daily for five consecutive days [29][30][31]. However, tDCS applied daily for five consecutive days over the primary somatosensory cortex (S1) bilaterally [32][33][34], the primary motor cortex (M1) bilaterally [35], and the sensorimotor cortex bilaterally [33], showed significant fatigue improvements. The discrepancy in the results might be related to the differences in stimulation targets, protocol duration (single session vs. five daily sessions) and the adapted current intensity applied in these studies (e.g., all of these protocols used intensities ≤2 mA).…”
Section: Introductionmentioning
confidence: 91%
“…Other studies in PwMS also showed no significant improvements on fatigue questionnaires from unilateral prefrontal or parietal tDCS stimulation applied daily for five consecutive days [29][30][31]. However, tDCS applied daily for five consecutive days over the primary somatosensory cortex (S1) bilaterally [32][33][34], the primary motor cortex (M1) bilaterally [35], and the sensorimotor cortex bilaterally [33], showed significant fatigue improvements. The discrepancy in the results might be related to the differences in stimulation targets, protocol duration (single session vs. five daily sessions) and the adapted current intensity applied in these studies (e.g., all of these protocols used intensities ≤2 mA).…”
Section: Introductionmentioning
confidence: 91%
“…The group of Tecchio et al focused on a personalized anodal tDCS approach targeting the whole-body primary somatosensory areas (S1) bilaterally, following the evidence of S1 reduced excitability and M1 hyperexcitability in PwMS with fatigue (109)(110)(111)(112). They used a tailored procedure with personalized electrodes based on the patients' brain MRI located in place through an MRI-guided neuronavigation system.…”
Section: Neurophysiology As Innovative Treatment For Fatigue In Ms Pamentioning
confidence: 99%
“…In addition, performance fatigability is the magnitude or rate of change in performance over a given time relative to a reference value. The effects of tDCS on performance fatigability in healthy participants [14][15][16] and in people with neurological impairments [17][18][19][20][21][22] has been previously investigated and has yielded ambiguous findings. The mixed results might be from a lack of standardized protocols and inconsistent definitions of fatigue, which makes comparison of fatigue outcomes between studies more challenging.…”
Section: Introductionmentioning
confidence: 99%